{"id":"NCT01159262","sponsor":"Hospira, now a wholly owned subsidiary of Pfizer","briefTitle":"Safety, Efficacy and Pharmacokinetic Study of Dexmedetomidine in Pediatrics Ages ≥28 Weeks to ≤44 Weeks Gestational Age","officialTitle":"A Phase II/III, Open-Label, Multicenter, Safety, Efficacy and Pharmacokinetic Study of Dexmedetomidine in Neonates Ages ≥28 Weeks to ≤44 Weeks Gestational Age","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2010-07","primaryCompletion":"2011-08","completion":"2011-08","firstPosted":"2010-07-09","resultsPosted":"2014-12-12","lastUpdate":"2015-08-13"},"enrollment":36,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Sedation"],"interventions":[{"type":"DRUG","name":"Midazolam","otherNames":[]},{"type":"DRUG","name":"Fentanyl/Morphine","otherNames":[]},{"type":"DRUG","name":"Dexmedetomidine","otherNames":["Precedex"]}],"arms":[{"label":"Dexmedetomidine 0.05 mcg/kg","type":"EXPERIMENTAL"},{"label":"Dexmedetomidine 0.1 mcg/kg","type":"EXPERIMENTAL"},{"label":"Dexmedetomidine 0.2 mcg/kg","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to investigate the safety, efficacy and pharmacokinetics (PK) of dexmedetomidine (DEX) at 3 different dose levels in infants, ages ≥28 weeks to ≤44 weeks gestational age, administered as a loading dose followed by a continuous infusion for a minimum of 6 hours and up to 24 hours in the neonatal intensive care unit (NICU), cardiac intensive care unit (CICU), or pediatric intensive care unit (PICU).","primaryOutcome":{"measure":"Percentage of Subjects Who Received Rescue Medication Midazolam for Sedation During Dexmedetomidine Infusion","timeFrame":"During study drug administration (6 to 24 hours)","effectByArm":[{"arm":"Dexmedetomidine 0.05 mcg/kg","deltaMin":7.1,"sd":null},{"arm":"Dexmedetomidine 0.1 mcg/kg","deltaMin":7.1,"sd":null},{"arm":"Dexmedetomidine 0.2 mcg/kg","deltaMin":25,"sd":null}],"pValues":[]},"eligibility":{"minAge":"28 Weeks","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":18,"countries":["United States","Guatemala"]},"refs":{"pmids":["24238862"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":14},"commonTop":["Anger","Hypoalbuminaemia","Hypokalaemia","Blood potassium decreased","Hypocalcaemia"]}}